相关实验视频

Updated: May 23, 2025

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Published on: January 7, 2019

开发基于循环的辐射追踪器,用于UPAR

Xingkai Wang¹, Xu Zhang¹, Siqi Zhang¹

¹State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Xian Nong Tan Street, Beijing, 100050, China.

|May 1, 2025

概括

研究人员开发了新型正子发射断层扫描 (PET) 放射性联体,用于成像尿激酶等离子素激活器受体 (uPAR). [64Cu]CARP-2显示出优越的瘤向和清除,这表明它有可能改善癌症诊断.

科学领域:

生物医学成像技术生物医学成像技术
放射化学放射化学是指辐射化学.
在瘤学瘤学.

背景情况:

泌尿酸酶等离子激素激活器 (uPA) 系统,特别是其受体 (uPAR),在癌症进展和转移中至关重要.
在癌症早期诊断和治疗中,针对 uPAR 的放射性对象至关重要.
为Upar成像开发特定和有效的放射追踪器仍然是一个关键的挑战.

研究的目的:

合成和评估基于循环的新型正子发射断层扫描 (PET) 放射性体,用于UPAR成像.
为了比较这些新型放射性质的性能与临床相关的标记物 ([64Cu]DOTA-AE105).
确定具有最佳瘤吸收,特异性和药理动力学特性的主要候选者.

主要方法:

开发了三种标记为[64Cu]的循环放射连体 ([64Cu]CARP-1,[64Cu]CARP-2,[64Cu]CARP-3),具有不同的二硫化物键配置.
在MC38瘤携带的小鼠模型中的体内评估.
评估瘤吸收,特异性,生物分布和药理动力学.
与[64Cu]DOTA-AE105.5进行比较.

主要成果:

这三种放射性连体均成功合成并用64Cu.Cu进行放射性标记.
[64Cu]CARP-2在新型候选物中表现出瘤放射性积累和特异性最高.
与[64Cu]DOTA-AE105相比,[64Cu]CARP-2的非特异性吸收减少,并且从正常组织中清除速度更快.
对于[64Cu]CARP-2观察到有利的药理动力学和生物分布特征.

结论:

[64Cu]CARP-2是一种有前途的新型PET放射性对象,用于UPAR成像.
它的增强瘤向性和有利的药理动力学特征表明,它有可能提高癌症的诊断准确性.
[64Cu]CARP-2需要进一步的临床前和临床研究,以PAR为准癌症成像.

关键词:

这是一种循环.在PET成像中使用PET成像.泌尿酸酶类型的塑原激活剂受体受体

更多相关视频

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Published on: May 29, 2017

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...